Education
About Us
Working with TipRanks
Follow Us
Neurogene (NGNE)
NASDAQ:NGNE
Total Valuation
Neurogene has a market cap or net worth of $285.72M. The enterprise value is $51.22M.
Market Cap$285.72M
Enterprise Value$51.22M
Share Statistics
Neurogene has 14,271,916 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,271,916
Owned by Insiders21.83%
Owned by Institutions<0.01%
Financial Efficiency
Neurogene’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -25.53%.
Return on Equity (ROE)-0.24
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-25.53%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee8.64K
Profits Per Employee-702.28K
Employee Count107
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Neurogene is ―. Neurogene’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value1.29
Price to FCF―
Price to Operating Cash Flow-5.87
PEG Ratio―
Income Statement
In the last 12 months, Neurogene had revenue of 925.00K and earned -75.14M in profits. Earnings per share was -4.28.
Revenue925.00K
Gross Profit-2.32M
Operating Income-82.61M
Pretax Income-75.14M
Net Income-75.14M
EBITDA-71.89M
Earnings Per Share (EPS)-4.28
Cash Flow
In the last 12 months, operating cash flow was -73.30M and capital expenditures -1.21M, giving a free cash flow of -74.51M billion.
Operating Cash Flow-73.30M
Free Cash Flow-74.51M
Free Cash Flow per Share-5.22
Dividends & Yields
Neurogene pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.96
52-Week Price Change-45.88%
50-Day Moving Average20.32
200-Day Moving Average19.56
Relative Strength Index (RSI)43.60
Average Volume (3m)117.61K
Important Dates
Neurogene upcoming earnings date is Nov 24, 2025, Before Open (Confirmed).
Last Earnings DateAug 11, 2025
Next Earnings DateNov 24, 2025
Ex-Dividend Date―
Financial Position
Neurogene as a current ratio of 20.84, with Debt / Equity ratio of 4.01%
Current Ratio20.84
Quick Ratio20.84
Debt to Market Cap<0.01
Net Debt to EBITDA1.73
Interest Coverage Ratio-6.88K
Taxes
In the past 12 months, Neurogene has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Neurogene EV to EBITDA ratio is -3.86, with an EV/FCF ratio of -3.88.
EV to Sales299.92
EV to EBITDA-3.86
EV to Free Cash Flow-3.88
EV to Operating Cash Flow-3.93
Balance Sheet
Neurogene has $274.52M in cash and marketable securities with $10.97M in debt, giving a net cash position of -$263.55M billion.
Cash & Marketable Securities$274.52M
Total Debt$10.97M
Net Cash-$263.55M
Net Cash Per Share-$18.47
Tangible Book Value Per Share$17.67
Margins
Gross margin is 256.43%, with operating margin of -8930.27%, and net profit margin of -8123.68%.
Gross Margin256.43%
Operating Margin-8930.27%
Pretax Margin-8123.68%
Net Profit Margin-8123.68%
EBITDA Margin-7771.35%
EBIT Margin-8122.38%
Analyst Forecast
The average price target for Neurogene is $46.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$46.75
Price Target Upside137.31% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-100.00%
EPS Growth Forecast-24.84%